Novartis (NVS) is trading at new all-time highs on Monday. Shares are up nearly 50% over the past 52 weeks. NVS maintains a 100% “Buy” technical opinion from Barchart. Novartis has benefitted in recent days from its CEO’s comments that the company will have essentially limited tariff exposure by mid-2026. Today’s Featured Stock Valued at $310.8 billion, Novartis (NVS) is a pharmaceutical giant with a portfolio that spans oncology, immunology, neuroscience, and more. Some of its well-known produ ...